Tyto Stethoscope vs EchoGo Amyloidosis

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tyto Stethoscope offers a broad remote examination platform for general practice, utilizing AI for multi-system diagnostics including basic heart assessments. In contrast, EchoGo Amyloidosis is a highly specialized AI tool focused solely on the early detection of cardiac amyloidosis from existing echocardiogram video clips. While both leverage AI in cardiology, their distinct scope, input data, and target clinical workflows make them suitable for different use cases.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and what is their primary clinical utility for patient care?

Tyto Stethoscope facilitates remote physical exams for various body systems, supporting both live and asynchronous telehealth workflows with guided instructions. Its primary utility is enabling comprehensive virtual visits and AI-powered clinical decision support for conditions like lung sound identification. EchoGo Amyloidosis integrates seamlessly by analyzing existing echocardiogram video clips to aid in the early detection of cardiac amyloidosis. Its primary utility is providing a 'suggestive' or 'not suggestive' diagnostic output to help identify at-risk patients and streamline referrals.

What are the reported accuracy and sensitivity metrics for the diagnostic capabilities of each tool?

Tyto Stethoscope offers AI-powered diagnostics and clinical decision support for lung sound identification, including wheezes, crackles, and rhonchi, with clinical validation demonstrating performance equivalent to or better than non-pulmonologist clinicians for rhonchi detection. EchoGo Amyloidosis demonstrates high diagnostic accuracy with 85% sensitivity and 93% specificity for identifying suspected cardiac amyloidosis, performing consistently across various CA subtypes.

For which medical specialties are these tools best suited, and what is the breadth of conditions they are designed to address?

Tyto Stethoscope is best suited for Family Medicine, Internal Medicine, and Pediatrics, enabling remote physical exams for a broad scope including heart, lungs, ears, throat, skin, and abdomen, along with vital sign measurements. EchoGo Amyloidosis is specifically designed for Cardiology, focusing exclusively on the early detection of cardiac amyloidosis by analyzing echocardiographic markers.

What is the depth of integration with existing EHR systems and IT infrastructure for each tool, particularly for multi-site rollouts?

Tyto Stethoscope has expanded its integration within Epic's MyChart, enabling health systems to easily access TytoCare-generated data in a patient's EHR and clinicians to access exam data directly within Epic. TytoCare uses APIs to post patient vitals directly into a patient's EHR. EchoGo Amyloidosis offers seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7, making it well-suited for efficient multi-site rollouts within hospital systems.

What is the expected learning curve for physicians and their staff to effectively utilize these tools in their practice?

Tyto Stethoscope features a guided examination process with on-device and in-app instructions, and offers structured learning programs, personalized training sessions, and a 'Welcome Visit' with a live trainer, suggesting a relatively low learning curve for conducting remote physical exams. EchoGo Amyloidosis analyzes existing echocardiogram video clips, implying a minimal learning curve for physicians beyond understanding and interpreting its 'suggestive' or 'not suggestive' diagnostic output, with no new hardware or software required and minimal training to onboard staff.

Beyond standard compliance, what specific security features protect patient data, and do these tools offer audit-trail capabilities?

Tyto Stethoscope ensures encrypted data transmission and HIPAA-compliant cloud storage for patient data. The provided information does not detail specific security features beyond compliance or explicit audit-trail capabilities. EchoGo Amyloidosis operates on a secure cloud-based SaaS model and is HIPAA compliant, with data anonymized and secured via VPN. The provided information does not explicitly detail audit-trail capabilities beyond general HIPAA compliance.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

Backers

Who funded each tool's parent company.